New Study Shows Effect of Neupro (Rotigotine Transdermal System) on … – MarketWatch (press release)

by admin on May 23, 2013

New Study Shows Effect of Neupro (Rotigotine Transdermal System) on
MarketWatch (press release)
ATLANTA, May 17, 2013 /PRNewswire via COMTEX/ — UCB today announced data from a double-blind, placebo-controlled study that found that Neupro? (Rotigotine Transdermal System) reduced total nocturnal systolic blood pressure (NSBP) elevations

and more »

View full post on restless leg syndrome – Google News

Leave a Comment

Previous post:

Next post: